Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition
Genetic Epidemiology and Pharmacogenetics of Dental Fluorosis
In Vivo Analysis of Thyroid Hormone Action
Preservation of Left Ventricular Geometry and Function
Anticoagulant Properties of Activated Protein C
Recently added grants:
An alpha-1A-adrenergic agonist drug for heart failure
Structural Basis for Antiarrhythmic Drug Action
Association of the Maternal Exome with Risk of an Aneuploid Conception
Genetic Repair of Familial Hypercholesterolemia
Cav-3 in Diabetic Myocardial Injury Following Ischemia/Reperfusion
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-006
Application #
6828776
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant